Clearstead Trust’s Arcosa ACA Stock Holding History

Clearstead Trust’s Portfolio ACA Stock Details ACA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-9	Closed	-$844	–	1004
2025 Q3	$844	Hold	9	–	–	﹤0.01%	1263
2025 Q2	$781	Buy	+9	New	+$753	﹤0.01%	1228

Other funds holding ACA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Clearstead Trust's ACA Position: Q4 2025 in Review

Clearstead Trust sold out of Arcosa (ACA) in Q4 2025, closing a stake of 9 shares — an estimated $844 sold.

Clearstead Trust first reported a position in ACA in Q2 2025 and held it in 2 quarters. The position peaked at $844 in Q3 2025. 365 funds tracked by Wall St. Rank hold ACA as of Q4 2025.

Clearstead Trust reported no remaining Arcosa position as of Q4 2025 after selling out during the quarter.
Clearstead Trust sold 9 Arcosa shares in Q4 2025, an estimated $844.
Clearstead Trust first reported a position in Arcosa in Q2 2025 and held it in 2 quarters.
Clearstead Trust's Arcosa position peaked at $844 in Q3 2025.
365 funds tracked by Wall St. Rank held Arcosa as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.